Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Shanghai Haohai Biological Technology Co., Ltd.*

上 海 昊 海 生 物 科 技 股 份 有 限 公 司

(a joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 6826) DATE OF BOARD MEETING

The board of directors (the "Board") of Shanghai Haohai Biological Technology Co., Ltd.*(the "Company") hereby announces that a meeting of the Board will be held on Wednesday, 30 August 2017 for the purpose of, among other matters, considering and approving the interim results of the Company and its subsidiaries for the six months ended 30 June 2017 and its publication and considering the payment of an interim dividend, if any.

By order of the Board

Shanghai Haohai Biological Technology Co., Ltd.*Hou Yongtai

Chairman

Shanghai, the PRC, 15 August 2017

As at the date of this announcement, the executive directors of the Company are Dr. Hou Yongtai, Mr. Wu Jianying, Mr. Huang Ming, Ms. Chen Yiyi and Mr. Tang Minjie; the non-executive directors of the Company are Ms. You Jie and Mr. Gan Renbao; and the independent non-executive directors of the Company are Mr. Chen Huabin, Mr. Shen Hongbo, Mr. Li Yuanxu, Mr. Zhu Qin and Mr. Wong Kwan Kit.

* For identification purpose only

Shanghai Haohai Biological Technology Co. Ltd. published this content on 15 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 15 August 2017 22:26:03 UTC.

Original documenthttp://www.3healthcare.com/files_m/notice_571.PDF

Public permalinkhttp://www.publicnow.com/view/BA92B65C4FF2854EDBF584BE3ACB5EF588C01218